Japan to get first batches of AstraZeneca vaccine from US | Inquirer News

Japan to get first batches of AstraZeneca vaccine from US

/ 11:10 AM April 01, 2021

Oxford/AstraZeneca's COVID-19 vaccine at a vaccination centre in Antwerp

FILE PHOTO: Empty vials of Oxford/AstraZeneca’s COVID-19 vaccine are seen at a vaccination center in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman/File Photo

TOKYO — Japan’s first doses of AstraZeneca Plc’s COVID-19 vaccine are coming from plants in the United States, the company said in an interview with the Asahi Newspaper.

The company had intended to import the undiluted vaccine from Europe until the imposition of export controls there, AstraZeneca’s head of vaccines in Japan Tomoo Tanaka said in an interview published on Thursday.

Article continues after this advertisement

Supplies of the vaccine will gradually shift to those made domestically by Japanese companies once regulatory approval is granted, expected in May, Tanaka said. He declined to say how much inventory of doses there are currently.

FEATURED STORIES

Daiichi Sankyo Co said last month it had begun production of AstraZeneca’s vaccine in Japan.

The Japanese government has arranged to buy 120 million doses of the vaccine, enough for 60 million people. Most of the doses will be made by Daiichi Sankyo, JCR Pharma and other local partners.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: AstraZeneca, Japan, United States

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.